Miphtel (Acetylcholine Chloride)

Acetylcholine chloride, the active ingredient in Miphtel, is a cholinergic agonist presented as a sterile ophthalmic solution for intraocular use. It is employed to lower intraocular pressure in glaucoma and to induce pupil constriction for diagnostic and surgical eye procedures. GNH USA supplies Miphtel as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Miphtel is a cholinergic agonist used in ophthalmology to manage conditions that benefit from pupil constriction and improved aqueous outflow.

Glaucoma: reduces intraocular pressure by facilitating aqueous humor drainage. Diagnostic procedures requiring miosis: produces pupil constriction to enhance visualization of ocular structures. Surgical procedures requiring miosis: induces controlled pupil constriction to protect intraocular tissues during surgery.

Miphtel may cause ocular and systemic reactions following intraocular administration.

Common Side Effects: - Blurred vision: temporary loss of visual clarity. - Eye pain or discomfort: mild irritation after dosing. - Headache: mild to moderate headache. - Brow ache: tenderness around the eyebrow region. - Photophobia: increased sensitivity to light. - Excessive tearing: increased lacrimation.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: sudden rise in intraocular pressure. - Severe ocular inflammation: uveitis or iritis. - Corneal edema: swelling of the cornea affecting vision. - Systemic cholinergic toxicity: bradycardia, hypotension, or bronchospasm. - Allergic reaction: rash, itching, or swelling of the eyelids.

Before prescribing Miphtel, clinicians should evaluate patient history and ocular status. - Assess intraocular pressure: confirm baseline pressure and angle status. - Monitor systemic cholinergic effects: watch for bradycardia or hypotension. - Avoid in hypersensitivity: discontinue if allergic reaction occurs. - Caution in asthma or COPD: cholinergic stimulation may exacerbate bronchospasm. - Do not use in narrow‑angle glaucoma: risk of precipitating acute closure. - Store at ambient temperature: keep in original container, protect from light and moisture.

Miphtel can interact with other ocular or systemic agents that affect cholinergic pathways.

Major Interactions (Avoid): - Anticholinergic eye drops (e.g., atropine): antagonize miotic effect. - Systemic anticholinergics: reduce therapeutic response. - Cholinesterase inhibitors: may potentiate cholinergic activity. - Other miotic agents (e.g., pilocarpine): risk of excessive miosis.

Moderate Interactions (Monitor Closely): - Topical ocular anesthetics: may increase corneal toxicity. - Systemic beta‑blockers: additive intraocular pressure lowering. - Systemic antihistamines: may affect pupil response. - Systemic cholinergic agents: monitor for systemic toxicity.